Evidence map›Paper›PMID 19227571›Full record

ArticleOncology (Williston Park, N.Y.)2008

Minimal progress, potential promise in small-cell lung cancer.

Taofeek Owonikoko, Suresh Ramalingam

Abstract read
PubMed
In one paragraph

Article in Oncology (Williston Park, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Taofeek Owonikoko
Suresh Ramalingam

Funding

Winship Cancer Institute, National Clinical Trials Network Lead Academic ParticipU10CA180864 · NCI · EMORY UNIVERSITY · PI BEITLER, JONATHAN, RAMALINGAM, SURESH S · 2014 to 2018
$2.9M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBiomarkers, TumorCarcinoma, Small CellChemotherapy, AdjuvantHumansLung NeoplasmsNeoplasm StagingRadiotherapy, AdjuvantAntineoplastic AgentsBiomarkers, Tumor

Identifiers

PMID19227571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.